Dermatology Grand Rounds
Wednesday, June 17th, 8am-12pm
676 North Saint Clair Street, Suite 1600 (16th Floor)
Presenting at 8:00 am
Updates on Current Research in the Department of Dermatology
Accelerating Diabetic Wound Healing through Depletion of Ganglioside
Duncan Dam, PhD
Lab of Dr. Amy Paller, MD
Topically delivered spherical nucleic acid nanoconjugates targeting TNF improve the psoriatic phenotype
Katherine Lewandowski, Ph.D.
Lab of Dr. Amy Paller, M.D
Dermatology and EDW Data Mining for Research Purposes
Beatrice Nardone, MD PhD
Research Assistant Professor in Dermatology
Department of Dermatology
Presenting at 10:45 am
What's New in Wound Healing?
Robert S Kirsner, M.D., PhD
Chairman (Interim) and Harvey Blank Professor Department of Dermatology and Cutaneous Surgery
Professor of Epidemiology and Public Health Director
University of Miami School of Medicine
Dr. Kirsner is a Tenured Professor, Interim Chairman and holds the endowed Harvey Blank Chair in Dermatology in the Department of Dermatology and Cutaneous Surgery at the University of Miami, Miller School of Medicine. He currently serves as director of the University of Miami Hospital Wound Center and Chief of Dermatology at the University of Miami Hospital. With research interests in Wound Healing and Skin Cancer Epidemiology, he is a recipient of National Institutes of Health, Center for Disease Control and Prevention, and American Cancer Society funding for his research. Independent of books, book chapters and abstracts, he has published over 425 articles.
Overall meeting objectives:
At the conclusion of this activity, participants should be able to:
1. Discuss new technology used in addressing dermatologic problems.
2. Understand the choices and risks for treating skin disease.
3. Discuss the ethical issues that arise in patient care.
4. Recognize the relevance of new laboratory discoveries to clinical issues.
The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement:
The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure: Amy S. Paller, MD, MS has disclosed the following relevant financial relationships:
Serves as a consultant (with honoraria ) for the following companies: AbbVie, Anacor Pharmaceuticals, Inc., Celgene Corporation, Chugai Pharma, Galderma Laboratories, L.P. LEO Pharma US, Novartis Pharmaceuticals Corp., Onset Dermatologics, Promius Pharma, LLC., Scioderm, Shire, and Stiefel a GSK company.
Serves as a Principal Investigator (no honoraria) for the following companies: Amgen, Anacor Pharmaceuticals, Inc., Scioderm, and TopMD.
FSM’s listed CME Leadership and Staff have nothing to disclose: John X. Thomas, Jr., PhD, Sr. Associate Dean for Medical Education, Genevieve Napier, CME Director, Jen Banys, Michelle Mallery, and Tristan Brown, CME Project Specialists.
Katherine Lewandowski, Ph.D. has nothing to disclose.
Duncan Dam, PhD has nothing to disclose.
Beatrice Nardone, MD, PhD has nothing to disclose.
Robert S Kirsner, M.D., PhD has disclosed the following:
Serves as a consultant (with honoraria) for Organogenesis and Acelity.
Dr. Kirsner's presentation will include off-label discussion of using Timolol for wound care.
Sponsored by: Department of Dermatology
The Next Grand Rounds will be held on Wednesday, July 15, 2015
Antigen-encapsulating PLG Nanoparticles: A Novel Method for the Tolerogenic Therapy of Autoimmune and Allergic Diseases
Presenting at 8:00 am
Stephen D. Miller, PhD
Judy Gugenheim Research Professor of Microbiology-Immunology
Northwestern University Feinberg School of Medicine